10% Owner Skaff Injects $3.2M into Vivos Therapeutics via Preferred Stock and Warrants
VVOS is trading near its 52-week low of $0.383 (7.8% above the low).
Summary
10% owner Michael Skaff bought $3.2M of convertible preferred stock and warrants in Vivos Therapeutics, a company with a $5.7M market cap and going concern warning. The purchase provides critical funding and converts $1M of debt to equity.
Key Events · Ownership and Investor Activity · VVOS
-
10% Owner Buys $3.2M in Preferred and Warrants
Michael C. Skaff, through V-Co Investors 4 LLC, acquired 2,749,330 shares of Series A Convertible Preferred Stock and warrants to purchase 2,749,330 common shares for $3.2 million, representing 55.8% of Vivos' market cap.
-
Financing Provides Critical Runway
The $3.2M injection comes as Vivos faces a going concern warning and Nasdaq delisting risk, with Q1 2026 cash burn accelerating. The capital likely extends operations and addresses near-term liquidity needs.
-
Debt Conversion Included
Part of the transaction converted a $1 million bridge promissory note into preferred stock, reducing debt and aligning insider interests with equity holders.
-
Conversion Price at Premium to Market
Preferred stock converts at $0.456 per share, above the current $0.41 stock price, and warrants are exercisable at the same price through June 2031, suggesting insider sees value above market.
Analysis · VVOS · Industrial Applications And Services
A $3.2 million lifeline has arrived for Vivos Therapeutics, which has been burning cash and warning of going concern risk. Michael C. Skaff, a 10% owner, purchased Series A Convertible Preferred Stock and warrants in an amount equal to over half the company's market cap. The preferred stock converts at $0.456, a premium to today's $0.41 price, and the warrants carry a five-year term. The deal also converts a $1 million bridge note into equity, cleaning up debt. While highly dilutive if converted, the capital infusion likely extends the company's runway and signals insider confidence in the face of Nasdaq delisting threats.
At the time of this filing, VVOS was trading at $0.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.7M. The 52-week trading range was $0.38 to $7.03. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.